Verici Dx Plc operates as a developer of advanced clinical diagnostics in organ transplant. It offers the following products for clinical validation and commercialization: Clarava and Tuteva. The Clarava product is a pre-transplant prognosis for the risk of early acute rejection. The Tuteva product is a post-transplant diagnostic focused upon acute cellular rejection, including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatinine levels. The company was founded on April 22, 2020 and is headquartered in Franklin, TN.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Verici Dx Plc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Verici Dx Plc market cap is $14M.
What is the 52-week high for Verici Dx Plc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Verici Dx Plc 52 week high is $0.065 as of October 16, 2025.
What is the 52-week low for Verici Dx Plc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Verici Dx Plc 52 week low is $0.0076 as of October 16, 2025.
What is Verici Dx Plc stock price today?
Verici Dx Plc stock price today is $0.0076.
What was Verici Dx Plc stock price yesterday?
Verici Dx Plc stock price yesterday was $0.01.
What is the PE ratio of Verici Dx Plc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Verici Dx Plc’s P/E ratio is -0.24.
What is the Price-to-Book ratio of Verici Dx Plc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Verici Dx Plc P/B ratio is 0.7429.
What is the 50-day moving average of Verici Dx Plc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Verici Dx Plc 50-day moving average is $0.0078.
